1. 14P Deep learning-based quantification of immune infiltrate for predicting response to pembrolizumab from pre-treatment biopsies of metastatic non-small cell lung cancer: A study on the PEMBRO-RT phase II trial. (December 2022) Authors: Spronck, J.; Eekelen, L.V.; Tessier, L.; Bogaerts, J.; van der Woude, L.; van den Heuvel, M.; Theelen, W.; Ciompi, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absolute configuration of the antimalarial erythro-mefloquine – vibrational circular dichroism and X-ray diffraction studies of mefloquine and its thiourea derivative. Issue 85 (26th August 2016) Authors: Kohout, M.; Vandenbussche, J.; Roller, A.; Tůma, J.; Bogaerts, J.; Bultinck, P.; Herrebout, W.; Lindner, W. Journal: RSC advances Issue: Volume 6:Issue 85(2016) Page Start: 81461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: a survey within the MINDACT cohort. (November 2022) Authors: Lopes Cardozo, J.; Veira, S.; Ait Hassou, L.; Uwimana, A.; Božović-Spasojević, I.; Bogaerts, J.; Cardoso, F.; Schmidt, M.; Rutgers, E.; Poncet, C.; Drukker, C. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. Issue 6842 (20th June 1992) Authors: Allen, S.; Tice, J.; Van de Perre, P.; Serufilira, A.; Hudes, E.; Nsengumuremyi, F.; Bogaerts, J.; Lindan, C.; Hulley, S. Journal: BMJ Issue: Volume 304:Issue 6842(1992) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Issue 2 (February 2015) Authors: Stahel, R.; Bogaerts, J.; Ciardiello, F.; de Ruysscher, D.; Dubsky, P.; Ducreux, M.; Finn, S.; Laurent-Puig, P.; Peters, S.; Piccart, M.; Smit, E.; Sotiriou, C.; Tejpar, S.; Van Cutsem, E.; Tabernero, J. Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial. Issue 3 (February 2015) Authors: Fei, F.; Messina, C.; Slaets, L.; Chakiba, C.; Cameron, D.; Bogaerts, J.; Bonnefoi, H. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Very low risk of locoregional breast cancer recurrence in the EORTC 10041/BIG 03-04 MINDACT trial: Analysis of risk factors including the 70-gene signature. (April 2018) Authors: Rutgers, E.; Aalders, K.; Poncet, C.; Cardoso, F.; Bogaerts, J.; Delaloge, S.; Thompson, A.; Tryfonidis, K.; Van't Veer, L.; Piccart, M.; Rubio, I. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗